Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Yvan Beaussant, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Beaussant Y, Nigam K. Expending Perspectives on the Potential for Psychedelic-Assisted Therapies to Improve the Experience of Aging. Am J Geriatr Psychiatry. 2023 Jan; 31(1):54-57. PMID: 36307304.
    Citations:    Fields:    
  2. Rosa WE, Sager Z, Miller M, Bernstein I, Doerner Rinaldi A, Addicott K, Ljuslin M, Adrian C, Back AL, Beachy J, Bossis AP, Breitbart WS, Cosimano MP, Fischer SM, Guss J, Knighton E, Phelps J, Richards BD, Richards WA, Tulsky JA, Williams MT, Beaussant Y. Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness. J Palliat Med. 2022 08; 25(8):1273-1281. PMID: 35285721; PMCID: PMC9467634.
    Citations:    Fields:    
  3. Maia LO, Beaussant Y, Garcia ACM. The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review. J Pain Symptom Manage. 2022 06; 63(6):e725-e738. PMID: 35157985.
    Citations:    Fields:    Translation:Humans
  4. Barnett BS, Beaussant Y, King F, Doblin R. Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey. J Psychoactive Drugs. 2022 Jul-Aug; 54(3):269-277. PMID: 34409921.
    Citations:    Fields:    
  5. Beaussant Y, Tulsky J, Guérin B, Schwarz-Plaschg C, Sanders JJ. Mapping an Agenda for Psychedelic-Assisted Therapy Research in Patients with Serious Illness. J Palliat Med. 2021 11; 24(11):1657-1666. PMID: 33848208; PMCID: PMC8823676.
    Citations: 1     Fields:    Translation:Humans
  6. Beaussant Y, Sanders J, Sager Z, Tulsky JA, Braun IM, Blinderman CD, Bossis AP, Byock I. Defining the Roles and Research Priorities for Psychedelic-Assisted Therapies in Patients with Serious Illness: Expert Clinicians' and Investigators' Perspectives. J Palliat Med. 2020 10; 23(10):1323-1334. PMID: 32233936.
    Citations: 5     Fields:    Translation:Humans
  7. Goldwasser F, Vinant P, Aubry R, Rochigneux P, Beaussant Y, Huillard O, Morin L. Timing of palliative care needs reporting and aggressiveness of care near the end of life in metastatic lung cancer: A national registry-based study. Cancer. 2018 07 15; 124(14):3044-3051. PMID: 29742292.
    Citations: 5     Fields:    Translation:Humans
  8. Beaussant Y, Daguindau E, Chauchet A, Rochigneux P, Tournigand C, Aubry R, Morin L. Hospital end-of-life care in haematological malignancies. BMJ Support Palliat Care. 2018 Sep; 8(3):314-324. PMID: 29434048.
    Citations: 11     Fields:    Translation:Humans
  9. Cretin E, Pazart L, Rousseau MC, Noé A, Decavel P, Chassagne A, Godard-Marceau A, Trimaille H, Mathieu-Nicot F, Beaussant Y, Gabriel D, Daneault S, Aubry R. Exploring the perceptions of physicians, caregivers and families towards artificial nutrition and hydration for people in permanent vegetative state: How can a photo-elicitation method help? PLoS One. 2017; 12(10):e0186776. PMID: 29073185.
    Citations: 2     Fields:    Translation:Humans
  10. Rochigneux P, Raoul JL, Beaussant Y, Aubry R, Goldwasser F, Tournigand C, Morin L. Use of chemotherapy near the end of life: what factors matter? Ann Oncol. 2017 04 01; 28(4):809-817. PMID: 27993817.
    Citations: 24     Fields:    Translation:Humans
  11. Gallais Sérézal I, Beaussant Y, Rochigneux P, Tournigand C, Aubry R, Lindelöf B, Morin L. End-of-life care for hospitalized patients with metastatic melanoma in France: a nationwide, register-based study. Br J Dermatol. 2016 Sep; 175(3):583-92. PMID: 27038100.
    Citations: 4     Fields:    Translation:Humans
  12. Morin L, Beaussant Y, Aubry R, Fastbom J, Johnell K. Aggressiveness of End-of-Life Care for Hospitalized Individuals with Cancer with and without Dementia: A Nationwide Matched-Cohort Study in France. J Am Geriatr Soc. 2016 09; 64(9):1851-7. PMID: 27459579.
    Citations: 5     Fields:    Translation:Humans
  13. Henriques J, Pazart L, Grigoryeva L, Muzard E, Beaussant Y, Haffen E, Moulin T, Aubry R, Ortega JP, Gabriel D. Bedside Evaluation of the Functional Organization of the Auditory Cortex in Patients with Disorders of Consciousness. PLoS One. 2016; 11(1):e0146788. PMID: 26789734.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  14. Beaussant Y, Mathieu-Nicot F, Pazart L, Tournigand C, Daneault S, Cretin E, Godard-Marceau A, Chassagne A, Trimaille H, Bouleuc C, Cuynet P, Deconinck E, Aubry R. Is shared decision-making vanishing at the end-of-life? A descriptive and qualitative study of advanced cancer patients' involvement in specific therapies decision-making. BMC Palliat Care. 2015 Nov 16; 14:61. PMID: 26572617.
    Citations: 5     Fields:    Translation:Humans
  15. Beaussant Y, Daguindau E, Pugin A, Mohty M, Avet-Loiseau H, Roos-Weil D, Michallet M, Chevalier P, Raus N, El-Cheikh J, Tabrizi R, Huyn A, Buzyn A, Socié G, Vincent L, Guilhot F, Yakoub-Agha I, Lenain P, François S, Beckerich F, Lioure B, Bulabois CE, Deconinck E. Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A Retrospective Study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Biol Blood Marrow Transplant. 2015 Aug; 21(8):1452-9. PMID: 25911579.
    Citations: 5     Fields:    Translation:Humans
  16. Malak S, Sotto JJ, Ceccaldi J, Colombat P, Casassus P, Jaulmes D, Rochant H, Cheminant M, Beaussant Y, Zittoun R, Bordessoule D. Ethical and clinical aspects of intensive care unit admission in patients with hematological malignancies: guidelines of the ethics commission of the French society of hematology. Adv Hematol. 2014; 2014:704318. PMID: 25349612.
    Citations: 4     
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Beaussant's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (68)
Co-Authors (6)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.